Fusion Antibodies Plc (FAB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Sales | 3,895 | 2,182 | 2,691 | 1,914 | 1,481 |
| Cost of Goods | 2,123 | 1,378 | 1,207 | 952 | 618 |
| Gross Profit | 1,772 | 804 | 1,483 | 961 | 863 |
| Operating Expenses | 2,831 | 2,312 | 2,194 | 835 | 836 |
| Operating Income | -1,059 | -1,508 | -711 | 127 | 28 |
| Interest Expense | 20 | 4 | 5 | 1 | 0 |
| Other Income | 6 | 13 | 4 | 0 | 0 |
| Pre-tax Income | -1,073 | -1,500 | -711 | 126 | 27 |
| Income Tax | -376 | -235 | -11 | 6 | -1,127 |
| Net Income Continuous | -697 | -1,264 | -700 | 120 | 1,154 |
| Net Income | $-697 | $-1,264 | $-700 | $120 | $1,154 |
| EPS Basic Total Ops | -0.03 | -0.06 | -0.04 | 0.01 | 0.05 |
| EPS Basic Continuous Ops | -0.03 | -0.06 | -0.04 | 0.01 | 0.05 |
| EPS Diluted Total Ops | -0.03 | -0.06 | -0.04 | 0.01 | 0.05 |
| EPS Diluted Continuous Ops | -0.03 | -0.06 | -0.04 | 0.01 | 0.05 |
| EBITDA(a) | $-431 | $-1,065 | $-637 | $160 | $50 |